NMPA Approval

Trimetazidine Dihydrochloride Sustained-release Tablets

Approval Number

国药准字H20213446

Company湖南明瑞制药股份有限公司

Registration Date

June 1, 2021

Drug Information

Generic Name

盐酸曲美他嗪缓释片

Dosage Form

片剂

Strength

35mg

Drug Type

化学药品

Registration Date

June 1, 2021

Company Information

Applicant Company

Company Name湖南明瑞制药股份有限公司

Company Address

湖南省长沙市浏阳经济技术开发区府前路221号

Manufacturing Company

Company Name湖南明瑞制药股份有限公司

Company Address

浏阳经济技术开发区康成路1号;湖南省长沙市浏阳经济技术开发区府前路221号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸曲美他嗪缓释片 - NMPA 批准文号 | MedPath